Education
About Us
Working with TipRanks
Follow Us
Argent Biopharma Ltd (AU:RGT)
:RGT
RGT Stock Chart & Stats
AU$0.08
>-AU$0.01(-2.00%)
At close: 4:00 PM EST
AU$0.08
>-AU$0.01(-2.00%)
Day’s Range― - ―
52-Week RangeAU$0.07 - AU$0.32
Previous CloseN/A
Volume362.25K
Average Volume (3M)48.38K
Market Cap
AU$5.75M
Enterprise ValueAU$13.11M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-1.47
Next Earnings
Feb 27, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.08
Shares Outstanding83,384,865
10 Day Avg. Volume51,424
30 Day Avg. Volume48,376
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-30.21
Revenue Forecast (FY)AU$36.55M
Argent Biopharma News
RGT FAQ
What was Argent Biopharma Ltd’s price range in the past 12 months?
Argent Biopharma Ltd lowest share price was AU$0.07 and its highest was AU$0.32 in the past 12 months.
What is Argent Biopharma Ltd’s market cap?
Argent Biopharma Ltd’s market cap is AU$5.75M.
When is Argent Biopharma Ltd’s upcoming earnings report date?
Argent Biopharma Ltd’s upcoming earnings report date is Feb 27, 2026 which is in 72 days.
How were Argent Biopharma Ltd’s earnings last quarter?
Argent Biopharma Ltd released its earnings results on Aug 28, 2025. The company reported -AU$0.079 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.079.
Is Argent Biopharma Ltd overvalued?
According to Wall Street analysts Argent Biopharma Ltd’s price is currently Overvalued.
Does Argent Biopharma Ltd pay dividends?
Argent Biopharma Ltd does not currently pay dividends.
What is Argent Biopharma Ltd’s EPS estimate?
Argent Biopharma Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Argent Biopharma Ltd have?
Argent Biopharma Ltd has 83,384,865 shares outstanding.
What happened to Argent Biopharma Ltd’s price movement after its last earnings report?
Argent Biopharma Ltd reported an EPS of -AU$0.079 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -6.897%.
Which hedge fund is a major shareholder of Argent Biopharma Ltd?
Currently, no hedge funds are holding shares in AU:RGT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Argent Biopharma Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
-59.48%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-77.55%
Trailing 12-Months
Company Description
Argent Biopharma Ltd
MGC Pharmaceuticals Ltd is a European-based specialist Medical Cannabis company, in Phytocannabinoid-based medicine within the biopharmaceutical industry. The company's principal business goal is to produces and supply quality Cannabinoid based pharmaceutical products for the emergent medical markets in Europe, North America and Australasia.
Technical Analysis
Genetic Technologies
―
Zelira Therapeutics
―
EVE Health Group Limited
―
Adherium Ltd.
―
Bio-Gene Technology Ltd.
―